Reproduction

Courts hand down conflicting decisions often. Here’s how this has played out with mifepristone

A federal judge in Texas ruled to withdraw the Food and Drug Administration’s approval of the abortion drug mifepristone, potentially making medication abortion less accessible nationwide

A judge’s bad decision about the abortion pill rests on stigma about abortion that harms health care

The end of Roe reshaped abortion access across the U.S. What does it take to track those changes?

Recent research offers a tantalizing glimpse at a future in which two men can have biological children together, but any human applications remain far in the future

Preeclampsia is a common pregnancy disorder, but doctors lacked a decisive way to predict its severity until now

Chemicals called phthalates—found in everything from detergent to plastic shower curtains—are tied to lower sperm counts and more miscarriages

A judge’s decision could ban mifepristone across the country and weaken the Food and Drug Administration’s authority

Pregnant people infected with SARS-CoV-2 are more likely to be admitted to an intensive care unit or die than those who are uninfected, but vaccination significantly reduces the risk

One in three cases of maternal sepsis can be prevented with a single dose of antibiotic, a study in low- and middle-income countries shows

A beating heart is neither a necessary nor sufficient standard to determine the start of life, making antiabortion heartbeat bills morally and legally wrong

As the Supreme Court’s Roe v. Wade reversal put reproduction into the political limelight, Scientific American explored a range of issues related to abortion and reproductive health